Sentiment-Signal
19,9
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.
Unternehmen & Branche
| Name | Biomea Fusion, Inc. |
|---|---|
| Ticker | BMEA |
| CIK | 0001840439 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 86,3 Mio. USD |
| Beta | -0,27 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -61,797,000 | -1.18 | 58,572,000 | 29,552,000 | |
| 2025-09-30 | 10-Q | -16,407,000 | -0.27 | 55,187,000 | 15,619,000 | |
| 2025-06-30 | 10-Q | -20,740,000 | -0.51 | 73,163,000 | 27,510,000 | |
| 2025-03-31 | 10-Q | -29,262,000 | -0.80 | 55,055,000 | 28,737,000 | |
| 2024-12-31 | 10-K | -29,302,000 | -0.81 | 79,938,000 | 51,573,000 | |
| 2024-09-30 | 10-K | -32,787,000 | -0.91 | |||
| 2024-09-30 | 10-Q | -32,787,000 | -0.91 | 110,419,000 | 75,972,000 | |
| 2024-06-30 | 10-Q | -37,276,000 | -1.03 | 136,164,000 | 103,948,000 | |
| 2024-06-30 | 10-K | -37,276,000 | -1.03 | |||
| 2024-03-31 | 10-Q | -39,061,000 | -1.09 | 168,494,000 | 135,314,000 | |
| 2024-03-31 | 10-K | -39,061,000 | -1.09 | |||
| 2023-12-31 | 10-K | -34,884,000 | -0.98 | 199,927,000 | 169,237,000 | |
| 2023-09-30 | 10-Q | -28,429,000 | -0.80 | 225,087,000 | 199,612,000 | |
| 2023-09-30 | 10-K | -28,429,000 | -0.80 | |||
| 2023-06-30 | 10-Q | -24,891,000 | -0.70 | 248,674,000 | 224,305,000 | |
| 2023-06-30 | 10-K | -24,891,000 | -0.70 | |||
| 2023-03-31 | 10-K | -29,051,000 | -0.98 | |||
| 2023-03-31 | 10-Q | -29,051,000 | -0.98 | 112,638,000 | 83,129,000 | |
| 2022-12-31 | 10-K | -25,314,000 | -0.86 | 129,307,000 | 108,539,000 | |
| 2022-09-30 | 10-K | -22,890,000 | -0.78 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.